on 05 Apr 2022
Last Applicant/ Owned by
Paul-Ehrlich-Strasse 15
Tübingen
DE
72076
Serial Number
90812123 filed on 06th Jul 2021
Registration Number
6693951 registered on 05th Apr 2022
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purpose Read More
Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software
Statistical services and modeling with respect to cancer treatment and cancer diagnosis
Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology
Medical and pharmaceutical services
No 90812123
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Nov 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
02th Nov 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
02th Nov 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
02th Nov 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
02th Nov 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
05th Apr 2022 | REGISTERED-PRINCIPAL REGISTER |
18th Jan 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
18th Jan 2022 | PUBLISHED FOR OPPOSITION |
29th Dec 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
11th Dec 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |